Sweden · Delayed Price · Currency is SEK Physitrack Statistics
Total Valuation
Physitrack has a market cap or net worth of SEK 131.39 million. The enterprise value is 170.07 million.
| Market Cap | 131.39M |
| Enterprise Value | 170.07M |
Important Dates
The next confirmed earnings date is Tuesday, July 21, 2026.
| Earnings Date | Jul 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Physitrack has 16.26 million shares outstanding.
| Current Share Class | 16.26M |
| Shares Outstanding | 16.26M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 48.21% |
| Owned by Institutions (%) | 15.22% |
| Float | 6.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 29.16 |
| PS Ratio | 0.88 |
| PB Ratio | 1.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.05 |
| P/OCF Ratio | 3.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.32, with an EV/FCF ratio of 3.95.
| EV / Earnings | n/a |
| EV / Sales | 1.14 |
| EV / EBITDA | 3.32 |
| EV / EBIT | 23.25 |
| EV / FCF | 3.95 |
Financial Position
The company has a current ratio of 0.44, with a Debt / Equity ratio of 0.40.
| Current Ratio | 0.44 |
| Quick Ratio | 0.28 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 1.01 |
| Interest Coverage | 1.58 |
Financial Efficiency
Return on equity (ROE) is -42.99% and return on invested capital (ROIC) is 2.26%.
| Return on Equity (ROE) | -42.99% |
| Return on Assets (ROA) | 1.76% |
| Return on Invested Capital (ROIC) | 2.26% |
| Return on Capital Employed (ROCE) | 4.67% |
| Weighted Average Cost of Capital (WACC) | 7.63% |
| Revenue Per Employee | 4.15M |
| Profits Per Employee | -2.56M |
| Employee Count | 36 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Physitrack has paid 641,243 in taxes.
| Income Tax | 641,243 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.85% in the last 52 weeks. The beta is 0.57, so Physitrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -44.85% |
| 50-Day Moving Average | 8.22 |
| 200-Day Moving Average | 12.14 |
| Relative Strength Index (RSI) | 52.56 |
| Average Volume (20 Days) | 36,929 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Physitrack had revenue of SEK 149.47 million and -92.13 million in losses. Loss per share was -5.70.
| Revenue | 149.47M |
| Gross Profit | 96.63M |
| Operating Income | 7.31M |
| Pretax Income | -67.14M |
| Net Income | -92.13M |
| EBITDA | 51.29M |
| EBIT | 7.31M |
| Loss Per Share | -5.70 |
Balance Sheet
The company has 4.76 million in cash and 43.45 million in debt, with a net cash position of -38.68 million or -2.38 per share.
| Cash & Cash Equivalents | 4.76M |
| Total Debt | 43.45M |
| Net Cash | -38.68M |
| Net Cash Per Share | -2.38 |
| Equity (Book Value) | 108.83M |
| Book Value Per Share | 6.69 |
| Working Capital | -26.66M |
Cash Flow
In the last 12 months, operating cash flow was 43.59 million and capital expenditures -480,567, giving a free cash flow of 43.11 million.
| Operating Cash Flow | 43.59M |
| Capital Expenditures | -480,567 |
| Depreciation & Amortization | 44.40M |
| Net Borrowing | -1.94M |
| Free Cash Flow | 43.11M |
| FCF Per Share | 2.65 |
Margins
Gross margin is 64.65%, with operating and profit margins of 4.89% and -61.64%.
| Gross Margin | 64.65% |
| Operating Margin | 4.89% |
| Pretax Margin | -44.92% |
| Profit Margin | -61.64% |
| EBITDA Margin | 34.31% |
| EBIT Margin | 4.89% |
| FCF Margin | 28.84% |
Dividends & Yields
Physitrack does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -70.12% |
| FCF Yield | 32.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Physitrack has an Altman Z-Score of 1.06 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.06 |
| Piotroski F-Score | 6 |